A New Era for PCSK9 Inhibition!

Today’s big news in Lipid Land is that the first oral PCSK9 inhibitor was approved by the FDA! The generic name of this agent, which mechanistically is a macrocyclic peptide, is enlicitide, and I prefer to stick with that since…












